BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22045386)

  • 21. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
    Isetti G; Maurer MC
    Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transglutaminase Activities of Blood Coagulant Factor XIII Are Dependent on the Activation Pathways and on the Substrates.
    Mohammed RDS; Ablan FDO; McCann NM; Hindi MM; Maurer MC
    Thromb Haemost; 2023 Apr; 123(4):380-392. PubMed ID: 36473493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A distinct effect of transient and sustained upregulation of cellular factor XIII in the goldfish retina and optic nerve on optic nerve regeneration.
    Sugitani K; Ogai K; Hitomi K; Nakamura-Yonehara K; Shintani T; Noda M; Koriyama Y; Tanii H; Matsukawa T; Kato S
    Neurochem Int; 2012 Aug; 61(3):423-32. PubMed ID: 22709671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arterial vimentin is a transglutaminase substrate: a link between vasomotor activity and remodeling?
    Gupta M; Greenberg CS; Eckman DM; Sane DC
    J Vasc Res; 2007; 44(5):339-44. PubMed ID: 17476115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood coagulation factor XIII: activation, substrates and structure of a transglutaminase].
    Sicker T; Hilgenfeld R
    Hamostaseologie; 2002 Feb; 22(1):20-7. PubMed ID: 12193981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative characterization of direct and indirect substrate probes for on-chip transamidating activity assay of transglutaminases.
    Lee K; Jung SH; Kong DH; Hwang BM; Han ET; Park SW; Park JH; Kim YM; Ha KS
    J Biotechnol; 2013 Dec; 168(4):324-30. PubMed ID: 24140601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor XIII: Structure and Function.
    Schroeder V; Kohler HP
    Semin Thromb Hemost; 2016 Jun; 42(4):422-8. PubMed ID: 27019464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel assay for factor XIII based on cross-linking of synthetic peptides: analysis of different substrates.
    Kusch M; Grundmann C; Keitel S; Seitz R; König H
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):575-80. PubMed ID: 16988554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global identification and analysis of isozyme-specific possible substrates crosslinked by transglutaminases using substrate peptides in mouse liver fibrosis.
    Tatsukawa H; Tani Y; Otsu R; Nakagawa H; Hitomi K
    Sci Rep; 2017 Mar; 7():45049. PubMed ID: 28327670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of substrates crosslinked by transglutaminases in liver and kidney fibrosis.
    Tatsukawa H; Takeuchi T; Shinoda Y; Hitomi K
    Anal Biochem; 2020 Sep; 604():113629. PubMed ID: 32061735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions.
    Stamnaes J; Fleckenstein B; Sollid LM
    Biochim Biophys Acta; 2008 Nov; 1784(11):1804-11. PubMed ID: 18793760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA.
    Sugimura Y; Hosono M; Wada F; Yoshimura T; Maki M; Hitomi K
    J Biol Chem; 2006 Jun; 281(26):17699-706. PubMed ID: 16636049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferred substrate sequences for transglutaminase 2: screening using a phage-displayed peptide library.
    Hitomi K; Kitamura M; Sugimura Y
    Amino Acids; 2009 Apr; 36(4):619-24. PubMed ID: 18651094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal Bone Deposition Occurs in Mice Deficient in Factor XIII-A and Transglutaminase 2.
    Cordell PA; Newell LM; Standeven KF; Adamson PJ; Simpson KR; Smith KA; Jackson CL; Grant PJ; Pease RJ
    Matrix Biol; 2015 Apr; 43():85-96. PubMed ID: 25680676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivity of fish and microbial transglutaminases on glutaminyl sites of peptides derived from threadfin bream myosin.
    Hemung BO; Li-Chan EC; Yongsawatdigul J
    J Agric Food Chem; 2008 Aug; 56(16):7510-6. PubMed ID: 18671401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures.
    Nakano Y; Addison WN; Kaartinen MT
    Bone; 2007 Oct; 41(4):549-61. PubMed ID: 17669706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of transglutaminase substrate preference by cDNA display coupled with next-generation sequencing and bioinformatics.
    Damnjanović J; Odake N; Fan J; Camagna M; Jia B; Kojima T; Nemoto N; Hitomi K; Nakano H
    Sci Rep; 2022 Aug; 12(1):13578. PubMed ID: 35945258
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.